Bayer Takes License For Homocysteine Assay

Law360, New York (October 25, 2004, 12:00 AM EDT) -- A unit of drug maker Bayer Group has agreed to take a license for a technology covering homocysteine assays, following Competitive Technologies’ victory in its five-year patent infringement lawsuit against LabCorp over the same technology.

Under the accord reached, Bayer was granted a license under the Competitive Technologies patent and will pay royalties on sales of Bayer homocysteine assays, the companies said in a joint release.

Customers who purchase Bayer homocysteine assays will be covered by the Bayer license from Competitive Technologies. Bayer customers such as...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.